Aphria Inc. (T:APHA*CA)

Business Focus: Alternative Medicine

Dec 07, 2018 17:00 ET
APHRIA INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of
Wolf Haldenstein Adler Freeman & Herz LLP  announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors that purchased or otherwise acquired...
Dec 06, 2018 05:30 ET
Aphria Announces Special Committee to Review Governance Processes Related to LATAM Acquisition
Board reiterates confidence in LATAM operations and strategy Undertakes comprehensive review to protect shareholders in face of inaccurate and misleading accusations by short-sellers LEAMINGTON, ON, Dec. 6, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced its Board of Directors has appointed a special committee (the "Special Committee") of independent directors to review the Company's previously completed acquisition of LATAM Holdings Inc. (the "Acquisition"), which closed on September 27, 2018, and confirm the Company's belief that it conform
Dec 06, 2018 05:30 ET
Aphria Announces Special Committee to Review Governance Processes Related to LATAM Acquisition
Board reiterates confidence in LATAM operations and strategy Undertakes comprehensive review to protect shareholders in face of inaccurate and misleading accusations by short-sellers LEAMINGTON, ON, Dec. 6, 2018 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced its Board of Directors has appointed a special committee (the "Special Committee") of independent directors to review the Company's previously completed acquisition of LATAM Holdings Inc. (the "Acquisition"), which closed on September 27, 2018, and confirm the Company's belief that it ...
Dec 04, 2018 07:21 ET
Aphria Unequivocally Stands Behind its LATAM Operations
Assets Well Positioned to Create Substantial Value for Shareholders Executive Management Demonstrates Belief in Company Through $3.1M Acquisition of Shares on December 3, 2018 LEAMINGTON, ON, Dec. 4, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today provides the following update on its Latin American operations, including its previously completed LATAM acquisition of LATAM Holdings Inc. consisting of licenses and other assets and related businesses in Colombia, Argentina and Jamaica and a right of first offer and refusal in respect of Brazil (collectively
Dec 04, 2018 07:21 ET
Aphria Unequivocally Stands Behind its LATAM Operations
Assets Well Positioned to Create Substantial Value for Shareholders Executive Management Demonstrates Belief in Company Through $3.1M Acquisition of Shares on December 3, 2018 LEAMINGTON, ON, Dec. 4, 2018 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today provides the following update on its Latin American operations, including its previously completed LATAM acquisition of LATAM Holdings Inc. consisting of licenses and other assets and related businesses in Colombia, Argentina and Jamaica and a right of first offer and refusal in respect of Brazil (colle...
Dec 03, 2018 14:00 ET
Aphria statement regarding short-seller report
LEAMINGTON, ON, Dec. 3, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) is aware of a short-seller report released earlier today which Aphria believes is a malicious and self-serving attempt to profit by manipulating Aphria's stock price at the expense of Aphria's shareholders.
Dec 03, 2018 14:00 ET
Aphria statement regarding short-seller report
LEAMINGTON, ON, Dec. 3, 2018 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) is aware of a short-seller report released earlier today which Aphria believes is a malicious and self-serving attempt to profit by manipulating Aphria's stock price at the expense of Aphria's shareholders....
Nov 30, 2018 17:02 ET
Tetra Bio-Pharma Closes Financing With Aphria Inc.
Tetra Bio-Pharma Inc (“Tetra” or “TBP”), (TSX VENTURE: TBP) (OTCQB: TBPMF), has closed a private placement of units (the “Private Placement”) with its strategic partner Aphria Inc. (“Aphria”) (TSX: APHA) (NYSE: APHA). Under the Private Placement,...
Nov 29, 2018 10:00 ET
Blending the Talent of the Beverage Industry to Create the Cannabis Drinks of the Future: Sproutly (SPR: CSE) (OTCQB: SRUTF), Corby Spirit and Wine Limited, Pernod Ricard SA, Aphria and HEXO Corporati
Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks releases a sector snapshot with a focus on the shift and demand for seasoned beverage industry experts to enter  the rapidly growing cannabis...
Nov 08, 2018 04:00 ET
Aphria to acquire CC Pharma, strengthening foothold in German medical cannabis market
Acquisition adds new vertical and strategic operations in key region of global growth strategy
Nov 08, 2018 04:00 ET
Aphria to acquire CC Pharma, strengthening foothold in German medical cannabis market
Acquisition adds new vertical and strategic operations in key region of global growth strategy ...
Nov 07, 2018 06:00 ET
Aphria and DCM Subsidiary Perennial Launch Joint Venture to Create Original, Consumer-Centric Brands Offering Cannabis-Infused Products
Joint venture partners Aphria's cannabis expertise with Perennial's international brand strategy experience
Nov 07, 2018 06:00 ET
Aphria and DCM Subsidiary Perennial Launch Joint Venture to Create Original, Consumer-Centric Brands Offering Cannabis-Infused Products
Joint venture partners Aphria's cannabis expertise with Perennial's international brand strategy experience...
Nov 05, 2018 09:31 ET
Rapid Dose Therapeutics Signs an Exclusive Preferred Global Vendor Agreement with Aphria
Toronto, Burlington, Ontario--(Newsfile Corp. - November 5, 2018) - ACME Resources Corp. ("ACME") and Rapid Dose Therapeutics Inc. ("RDT") are pleased to announce that RDT and Aphria Inc. ("Aphria") (TSX: APHA) (NYSE: APHA) have signed a definitive agreement granting Aphria exclusive preferred global vendor status for the production and sales of RDT's QuickStrip™ technology for both medicinal and adult-use cannabis markets around the world.
Nov 05, 2018 06:30 ET
Aphria Shareholders Elect Four New Directors
LEAMINGTON, ON, Nov. 5, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced the results of the shareholder resolutions considered at the Company's Annual and Special Meeting of Shareholders (the "Meeting") held on November 2, 2018.
Nov 01, 2018 23:43 ET
Aphria's Australian-Based Partner Althea Granted Manufacture Licence
LEAMINGTON, ON, Nov. 1, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its Australian-based partner Althea Company Pty Ltd. ("Althea" or the "Australian Company") has been granted a Manufacture Licence by the Australian Government's Office of Drug Control.